BiotechTube
Home/Pipeline/GEMINI System

GEMINI System

Not Specified

Pre-clinicalActive

Key Facts

Indication
Not Specified
Phase
Pre-clinical
Status
Active
Company
SFC Fluidics

About SFC Fluidics

SFC Fluidics is a private medical device company leveraging proprietary microfluidic technology to create next-generation drug delivery systems. Its primary focus is the PANDA™ system, a patch pump for insulin delivery aimed at offering greater precision, safety, and convenience for diabetes patients. The company appears to be in a pre-revenue or early development stage, advancing its lead device while exploring broader applications of its platform. Leadership comprises a small, seasoned team with expertise in medical devices, microfluidics, and diabetes care.

View full company profile

Therapeutic Areas

DiabetesOncologyChronic Pain

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved